These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism. Fernández de Mattos S; Essafi A; Soeiro I; Pietersen AM; Birkenkamp KU; Edwards CS; Martino A; Nelson BH; Francis JM; Jones MC; Brosens JJ; Coffer PJ; Lam EW Mol Cell Biol; 2004 Nov; 24(22):10058-71. PubMed ID: 15509806 [TBL] [Abstract][Full Text] [Related]
4. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients. Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759 [TBL] [Abstract][Full Text] [Related]
5. Repression of BCL-6 is required for the formation of human memory B cells in vitro. Kuo TC; Shaffer AL; Haddad J; Choi YS; Staudt LM; Calame K J Exp Med; 2007 Apr; 204(4):819-30. PubMed ID: 17403935 [TBL] [Abstract][Full Text] [Related]
7. Activated STAT5 proteins induce activation of the PI 3-kinase/Akt and Ras/MAPK pathways via the Gab2 scaffolding adapter. Nyga R; Pecquet C; Harir N; Gu H; Dhennin-Duthille I; Régnier A; Gouilleux-Gruart V; Lassoued K; Gouilleux F Biochem J; 2005 Aug; 390(Pt 1):359-66. PubMed ID: 15833084 [TBL] [Abstract][Full Text] [Related]
8. Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation. Liu X; Robinson GW; Hennighausen L Mol Endocrinol; 1996 Dec; 10(12):1496-506. PubMed ID: 8961260 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways. Nagy ZS; Wang Y; Erwin-Cohen RA; Aradi J; Monia B; Wang LH; Stepkowski SM; Rui H; Kirken RA J Leukoc Biol; 2002 Oct; 72(4):819-28. PubMed ID: 12377952 [TBL] [Abstract][Full Text] [Related]
10. IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells. Teng Y; Takahashi Y; Yamada M; Kurosu T; Koyama T; Miura O; Miki T Eur J Cell Biol; 2007 Oct; 86(10):581-9. PubMed ID: 17651861 [TBL] [Abstract][Full Text] [Related]
11. Delineation and mapping of Stat5 isoforms activated by granulocyte colony-stimulating factor in myeloid cells. Chakraborty A; Dyer KF; Tweardy DJ Blood Cells Mol Dis; 2000 Aug; 26(4):320-30. PubMed ID: 11042034 [TBL] [Abstract][Full Text] [Related]
12. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. Nosaka T; Kawashima T; Misawa K; Ikuta K; Mui AL; Kitamura T EMBO J; 1999 Sep; 18(17):4754-65. PubMed ID: 10469654 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain. van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637 [TBL] [Abstract][Full Text] [Related]
14. Human leukemias with mutated FLT3 kinase are synergistically sensitive to FLT3 and Hsp90 inhibitors: the key role of the STAT5 signal transduction pathway. Yao Q; Nishiuchi R; Kitamura T; Kersey JH Leukemia; 2005 Sep; 19(9):1605-12. PubMed ID: 16034464 [TBL] [Abstract][Full Text] [Related]
15. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C. Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967 [TBL] [Abstract][Full Text] [Related]
16. Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases. Paukku K; Valgeirsdóttir S; Saharinen P; Bergman M; Heldin CH; Silvennoinen O Biochem J; 2000 Feb; 345 Pt 3(Pt 3):759-66. PubMed ID: 10642538 [TBL] [Abstract][Full Text] [Related]
17. Synergistic action of prolactin (PRL) and androgen on PRL-inducible protein gene expression in human breast cancer cells: a unique model for functional cooperation between signal transducer and activator of transcription-5 and androgen receptor. Carsol JL; Gingras S; Simard J Mol Endocrinol; 2002 Jul; 16(7):1696-710. PubMed ID: 12089361 [TBL] [Abstract][Full Text] [Related]
18. Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor. Le MN; Kohanski RA; Wang LH; Sadowski HB Mol Endocrinol; 2002 Dec; 16(12):2764-79. PubMed ID: 12456798 [TBL] [Abstract][Full Text] [Related]
19. Cotreatment with suberanoylanilide hydroxamic acid and 17-allylamino 17-demethoxygeldanamycin synergistically induces apoptosis in Bcr-Abl+ Cells sensitive and resistant to STI571 (imatinib mesylate) in association with down-regulation of Bcr-Abl, abrogation of signal transducer and activator of transcription 5 activity, and Bax conformational change. Rahmani M; Reese E; Dai Y; Bauer C; Kramer LB; Huang M; Jove R; Dent P; Grant S Mol Pharmacol; 2005 Apr; 67(4):1166-76. PubMed ID: 15625278 [TBL] [Abstract][Full Text] [Related]
20. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway. Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]